MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.340
-0.040
-1.68%
Opening 10:15 03/31 EDT
OPEN
2.380
PREV CLOSE
2.380
HIGH
2.380
LOW
2.340
VOLUME
2.53K
TURNOVER
4.54K
52 WEEK HIGH
4.840
52 WEEK LOW
1.680
MARKET CAP
195.67M
P/E (TTM)
-2.6254
1D
5D
1M
3M
1Y
5Y
SVB Securities Sticks to Their Buy Rating for AC Immune SA (ACIU)
TipRanks · 03/20 13:47
AC Immune: Dementia-Focused Swiss Biotech With A Sad History Of Failures
Seeking Alpha · 03/18 13:00
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Paratek Pharmaceuticals (PRTK) and AC Immune SA (ACIU)
TipRanks · 03/17 10:30
AC Immune Non-GAAP EPS of -CHF 0.81, revenue of CHF 3.9M
Seeking Alpha · 03/16 11:57
BRIEF-AC Immune Reports Full Year 2022 Financial Results And Provides Corporate Update
Reuters · 03/16 11:30
AC Immune FY Adjusted EPS CHF(0.81) Up From CHF(0.99) YoY, Sales CHF3.94M
Benzinga · 03/16 11:09
Earnings Scheduled For March 16, 2023
Benzinga · 03/16 10:59
Notable earnings before Thursday's open
Seeking Alpha · 03/15 15:30
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers kinds of AC Immune SA stock information, including NASDAQ:ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.